Genome-wide association study of response to cognitive behavioural therapy in children with anxiety disorders

[thumbnail of Open Access]
Preview
Text (Open Access) - Published Version
· Available under License Creative Commons Attribution.
· Please see our End User Agreement before downloading.
| Preview
Available under license: Creative Commons Attribution
[thumbnail of Coleman et al_Genome wide association study of response to CBT in children with anxiety disorders_2016.pdf]
Preview
Text - Accepted Version
· Please see our End User Agreement before downloading.
| Preview

Please see our End User Agreement.

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

Add to AnyAdd to TwitterAdd to FacebookAdd to LinkedinAdd to PinterestAdd to Email

Coleman, J. R. I., Lester, K. J., Keers, R., Roberts, S., Curtis, C., Arendt, K., Bogels, S., Cooper, P., Creswell, C., Dalgleish, T., Hartman, C. A., Heiervang, E. R., Hotzel, K., Hudson, J. L., In-Albon, T., Lavallee, K., Lyneham, H. J., Marin, C. E., Meiser-Stedman, R., Morris, T., Nauta, M. H., Rapee, R. M., Schneider, S., Schneider, S. C., Silverman, W. K., Thastum, M., Thirlwall, K., Waite, P. orcid id iconORCID: https://orcid.org/0000-0002-1967-8028, Wergeland, G. J., Breen, G. and Eley, T. C. (2016) Genome-wide association study of response to cognitive behavioural therapy in children with anxiety disorders. British Journal of Psychiatry, 209 (3). pp. 236-243. ISSN 1472-1465 doi: 10.1192/bjp.bp.115.168229

Abstract/Summary

Background Anxiety disorders are common, and cognitive–behavioural therapy (CBT) is a first-line treatment. Candidate gene studies have suggested a genetic basis to treatment response, but findings have been inconsistent. Aims To perform the first genome-wide association study (GWAS) of psychological treatment response in children with anxiety disorders (n = 980). Method Presence and severity of anxiety was assessed using semi-structured interview at baseline, on completion of treatment (post-treatment), and 3 to 12 months after treatment completion (follow-up). DNA was genotyped using the Illumina Human Core Exome-12v1.0 array. Linear mixed models were used to test associations between genetic variants and response (change in symptom severity) immediately post-treatment and at 6-month follow-up. Results No variants passed a genome-wide significance threshold (P = 5×10−8) in either analysis. Four variants met criteria for suggestive significance (P<5×10−6) in association with response post-treatment, and three variants in the 6-month follow-up analysis. Conclusions This is the first genome-wide therapygenetic study. It suggests no common variants of very high effect underlie response to CBT. Future investigations should maximise power to detect single-variant and polygenic effects by using larger, more homogeneous cohorts.

Altmetric Badge

Item Type Article
URI https://reading-clone.eprints-hosting.org/id/eprint/51840
Identification Number/DOI 10.1192/bjp.bp.115.168229
Refereed Yes
Divisions Life Sciences > School of Psychology and Clinical Language Sciences > Department of Psychology
Life Sciences > School of Psychology and Clinical Language Sciences > Development
Life Sciences > School of Psychology and Clinical Language Sciences > Psychopathology and Affective Neuroscience
Life Sciences > School of Psychology and Clinical Language Sciences > Anxiety and Depression in Young People (AnDY)
Publisher Royal College of Psychiatrists
Download/View statistics View download statistics for this item

Downloads

Downloads per month over past year

University Staff: Request a correction | Centaur Editors: Update this record

Search Google Scholar